An assessment of nucleic acid amplification testing for active mycobacterial infection



Download 12.08 Mb.
Page55/56
Date28.05.2018
Size12.08 Mb.
#51325
1   ...   48   49   50   51   52   53   54   55   56

Appendix J Alternative NAAT fees


Table 114 The effect on the ICER of alternative NAAT item fees

NAAT fee

ICER

$28.65

Dominant

$40.00

Dominant

$70.00

$26,768

$82.00

$39,560

$100.50

$59,281

$130.00

$90,728

$200.00

$165,348

Note: Figures in bolded text were used in the base case analysis.

Table 115 The effect on the financial implications of alternative NAAT item fees



-

2015

2016

2017

2018

2019

NAAT fee: $28.65

-

-

-

-

-

Total cost of NAAT for TB

$538,276

$562,973

$587,640

$612,336

$637,004

Total cost of NAAT (inc. NAAT for NTM)

$1,759,496

$1,840,223

$1,920,855

$2,001,581

$2,082,214

NAAT fee: $40.00

-

-

-

-

-

Total cost of NAAT for TB

$751,520

$786,000

$820,440

$854,920

$889,360

Total cost of NAAT (inc. NAAT for NTM)

$1,972,740

$2,063,250

$2,153,655

$2,244,165

$2,334,570

NAAT fee: $70.00

-

-

-

-

-

Total cost of NAAT for TB

$1,315,160

$1,375,500

$1,435,770

$1,496,110

$1,556,380

Total cost of NAAT (inc. NAAT for NTM)

$2,536,380

$2,652,750

$2,768,985

$2,885,355

$3,001,590

NAAT fee: $82.00

-

-

-

-

-

Total cost of NAAT for TB

$1,540,616

$1,611,300

$1,681,902

$1,752,586

$1,823,188

Total cost of NAAT (inc. NAAT for NTM)

$2,761,836

$2,888,550

$3,015,117

$3,141,831

$3,268,398

NAAT fee: $100.50

-

-

-

-

-

Total cost of NAAT for TB

$1,888,194

$1,974,825

$2,061,356

$2,147,987

$2,234,517

Total cost of NAAT (inc. NAAT for NTM)

$3,109,414

$3,252,075

$3,394,571

$3,537,232

$3,679,727

NAAT fee: $130.00

-

-

-

-

-

Total cost of NAAT for TB

$2,442,440

$2,554,500

$2,666,430

$2,778,490

$2,890,420

Total cost of NAAT (inc. NAAT for NTM)

$3,663,660

$3,831,750

$3,999,645

$4,167,735

$4,335,630

NAAT fee: $200.00

-

-

-

-

-

Total cost of NAAT for TB

$3,757,600

$3,930,000

$4,102,200

$4,274,600

$4,446,800

Total cost of NAAT (inc. NAAT for NTM)

$4,978,820

$5,207,250

$5,435,415

$5,663,845

$5,892,010

Note: Figures in bolded text were used in the base-case financial analysis.

References


Abbara, A & Davidson, RN 2011, 'Etiology and management of genitourinary tuberculosis', Nature Reviews Urology, vol. 8, no. 12, pp. 678–688.

Abdalla, CM, de Oliveira, ZN, Sotto, MN, Leite, KR, Canavez, FC & de Carvalho, CM 2009, 'Polymerase chain reaction compared to other laboratory findings and to clinical evaluation in the diagnosis of cutaneous tuberculosis and atypical mycobacteria skin infection', International Journal of Dermatology, vol. 48, no. 1, pp. 27–35.

Abes, GT, Abes, FLLB & Jamir, JC 2011, 'The variable clinical presentation of tuberculosis otitis media and the importance of early detection', Otology and Neurotology, vol. 32, no. 4, pp. 539–543.

Ablanedo-Terrazas, Y, Alvarado-de la Barrera, C, Hernández-Juan, R, Ruiz-Cruz, M & Reyes-Terán, G 2014, 'Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV-infected patients', The Laryngoscope, vol. 124, no. 6, pp. 1382–1385.

Abubakar, I, Zignol, M, Falzon, D, Raviglione, M, Ditiu, L, Masham, S, Adetifa, I, Ford, N, Cox, H, Lawn, SD, Marais, BJ, McHugh, TD, Mwaba, P, Bates, M, Lipman, M, Zijenah, L, Logan, S, McNerney, R, Zumla, A, Sarda, K, Nahid, P, Hoelscher, M, Pletschette, M, Memish, ZA, Kim, P, Hafner, R, Cole, S, Migliori, GB, Maeurer, M, Schito, M & Zumla, A 2013, 'Drug-resistant tuberculosis: time for visionary political leadership', The Lancet Infectious Diseases, vol. 13, no. 6, pp. 529–539.

Al-Ateah, SM, Al-Dowaidi, MM & El-Khizzi, NA 2012, 'Evaluation of direct detection of Mycobacterium tuberculosis complex in respiratory and non-respiratory clinical specimens using the Cepheid GeneXpert® system', Saudi Medical Journal, vol. 33, no. 10, pp. 1100–1105.

Al-Mezaine, HS, Al-Muammar, A, Kangave, D & Abu El-Asrar, AM 2008, 'Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis', International Ophthalmology, vol. 28, no. 6, pp. 413–423.

Al-Serhani, AM 2001, 'Mycobacterial infection of the head and neck: presentation and diagnosis', The Laryngoscope, vol. 111, no. 11, pp. 2012–2016.

American Thoracic Society 1992, 'Control of tuberculosis in the United States', American Review of Respiratory Disease, vol. 146, no. 6, pp. 1623–1633.

Ani, A, Okpe, S, Akambi, M, Ejelionu, E, Yakubu, B, Owolodun, O, Ekeh, P, Oche, A, Tyem, D & Idoko, J 2009, 'Comparison of a DNA based PCR method with conventional methods for the detection of M. tuberculosis in Jos, Nigeria', Journal of Infection in Developing Countries, vol. 3, no. 6, pp. 470–475.

Armitage, P, Berry, G & Matthews, JNS 2002, Statistical methods in medical research, fourth edn, Blackwell Science, Oxford.

Association of Public Health Laboratories 2013, Fact sheet: Cepheid GeneXpert® MTB/RIF assay. Laboratory considerations for use of Cepheid GeneXpert® MTB/RIF Assay, viewed 18 June 2014,



.

Australian Government Department of Health 2012, National Hospital Cost Data Collection: Cost Report Round 14 (2009–10), Commonwealth of Australia, viewed 15 September 2014,

Awaisu, A, Haniki Nik Mohamed, M, Noordin, NM, Muttalif, AR, Aziz, NA, Syed Sulaiman, SA & Mahayiddin, AA 2012, 'Impact of connecting tuberculosis directly observed therapy short-course with smoking cessation on health-related quality of life', Tobacco Induced Diseases, vol. 10, p. 2.

Babikako, HM, Neuhauser, D, Katamba, A & Mupere, E 2010, 'Feasibility, reliability and validity of health-related quality of life questionnaire among adult pulmonary tuberculosis patients in urban Uganda: cross-sectional study', Health and Quality of Life Outcomes, vol. 8, p. 93.

Balcells, ME, Garcia, P, Chanqueo, L, Bahamondes, L, Lasso, M, Gallardo, AM & Cifuentes, L 2012, 'Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile', International Journal of Tuberculosis and Lung Disease, vol. 16, no. 10, pp. 1349–1353.

Bandolier editorial 1999, 'Diagnostic testing emerging from the gloom?', Bandolier, vol. 70.

Bani-Hani, KE, Yaghan, RJ, Matalka, II & Mazahreh, TS 2005, 'Tuberculous mastitis: a disease not to be forgotten', International Journal of Tuberculosis and Lung Disease, vol. 9, no. 8, pp. 920–925.

Bates, M, O'Grady, J, Maeurer, M, Tembo, J, Chilukutu, L, Chabala, C, Kasonde, R, Mulota, P, Mzyece, J, Chomba, M, Mukonda, L, Mumba, M, Kapata, N, Rachow, A, Clowes, P, Hoelscher, M, Mwaba, P & Zumla, A 2013, 'Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study', The Lancet Infectious Diseases, vol. 13, no. 1, pp. 36–42.

Baveja, CP, Gumma, V, Jain, M, Choudhary, M, Talukdar, B & Sharma, VK 2009, 'Newer methods over the conventional diagnostic tests for tuberculous meningitis: do they really help?', Tropical Doctor, vol. 39, no. 1, pp. 18–20.

Ben Kahla, I, Ben Selma, W, Marzouk, M, Ferjeni, A, Ghezal, S & Boukadida, J 2011, 'Evaluation of a simplified IS6110 PCR for the rapid diagnosis of Mycobacterium tuberculosis in an area with high tuberculosis incidence', Pathologie Biologie, vol. 59, no. 3, pp. 161–165.

Berbari, EF, Hanssen, AD, Duffy, MC, Steckelberg, JM & Osmon, DR 1998, 'Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature', American Journal of Orthopedics, vol. 27, no. 3, pp. 219–227.

Bhanothu, V, Theophilus, JP & Rozati, R 2014, 'Use of endo-ovarian tissue biopsy and pelvic aspirated fluid for the diagnosis of female genital tuberculosis by conventional versus molecular methods', PLoS ONE, vol. 9, no. 5.

Bhanu, NV, Singh, UB, Chakraborty, M, Suresh, N, Arora, J, Rana, T, Takkar, D & Seth, P 2005, 'Improved diagnostic value of PCR in the diagnosis of female genital tuberculosis leading to infertility', Journal of Medical Microbiology, vol. 54, no. 10, pp. 927–931.

Bhigjee, AI, Padayachee, R, Paruk, H, Hallwirth-Pillay, KD, Marais, S & Connoly, C 2007, 'Diagnosis of tuberculous meningitis: clinical and laboratory parameters', International Journal of Infectious Diseases, vol. 11, no. 4, pp. 348–354.

Biadglegne, F, Mulu, A, Rodloff, AC & Sack, U 2014, 'Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia', Tuberculosis, vol. 94, no. 5, pp. 502–505.

Boehme, CC, Nabeta, P, Hillemann, D, Nicol, MP, Shenai, S, Krapp, F, Allen, J, Tahirli, R, Blakemore, R, Rustomjee, R, Milovic, A, Jones, M, O'Brien, SM, Persing, DH, Ruesch-Gerdes, S, Gotuzzo, E, Rodrigues, C, Alland, D & Perkins, MD 2010, 'Rapid molecular detection of tuberculosis and rifampin resistance', New England Journal of Medicine, vol. 363, no. 11, pp. 1005–1015.

Bogner, JR, Rusch-Gerdes, S, Mertenskotter, T, Loch, O, Emminger, C, Baumgarten, R, Brockmeyer, NH, Brockhaus, W, Jablonowski, H, Stoehr, A, Roth, A, Albrecht, H, Roth, K, Tschauder, S, Dietrich, M & German, ASG 1997, 'Patterns of Mycobacterium avium culture and PCR positivity in immunodeficient HIV-infected patients: Progression from localized to systemic disease', Scandinavian Journal of Infectious Diseases, vol. 29, no. 6, pp. 579-584.

Borchardt, RA & Rolston, KV 2013, 'Nontuberculous mycobacterial infections: in vitro growth rates are clues to sites and susceptibility', Journal of the American Academy of Physician Assistants, vol. 26, no. 3, pp. 18, 25.

Borrell, S & Gagneux, S 2009, 'Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis', International Journal of Tuberculosis and Lung Disease, vol. 13, no. 12, pp. 1456–1466.

Boyle, D & Pai, M 2012, Tuberculosis Diagnostic Technology Landscape. , UNITAID, World Health Organization, Geneva Switzerland, viewed 18 November 2014,





Download 12.08 Mb.

Share with your friends:
1   ...   48   49   50   51   52   53   54   55   56




The database is protected by copyright ©ininet.org 2024
send message

    Main page